Published in Infect Immun on April 01, 2002
Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin Microbiol Rev (2003) 3.39
Anaplasma phagocytophilum and Ehrlichia chaffeensis: subversive manipulators of host cells. Nat Rev Microbiol (2010) 1.57
Differential expression and sequence conservation of the Anaplasma marginale msp2 gene superfamily outer membrane proteins. Infect Immun (2006) 1.39
Ehrlichia chaffeensis expresses macrophage- and tick cell-specific 28-kilodalton outer membrane proteins. Infect Immun (2005) 1.32
Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. Infect Immun (2003) 1.27
Surface-exposed proteins of Ehrlichia chaffeensis. Infect Immun (2007) 1.26
Molecular heterogeneity of Ehrlichia chaffeensis isolates determined by sequence analysis of the 28-kilodalton outer membrane protein genes and other regions of the genome. Infect Immun (2003) 1.09
Total, membrane, and immunogenic proteomes of macrophage- and tick cell-derived Ehrlichia chaffeensis evaluated by liquid chromatography-tandem mass spectrometry and MALDI-TOF methods. Infect Immun (2008) 1.07
Targeted and random mutagenesis of Ehrlichia chaffeensis for the identification of genes required for in vivo infection. PLoS Pathog (2013) 1.03
Virulence potential of Ehrlichia chaffeensis strains of distinct genome sequences. Infect Immun (2007) 1.02
Expression of members of the 28-kilodalton major outer membrane protein family of Ehrlichia chaffeensis during persistent infection. Infect Immun (2004) 1.02
Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen. Trans Am Clin Climatol Assoc (2004) 1.01
Ehrlichia chaffeensis transcriptome in mammalian and arthropod hosts reveals differential gene expression and post transcriptional regulation. PLoS One (2011) 0.96
Transcription analysis of the major antigenic protein 1 multigene family of three in vitro-cultured Ehrlichia ruminantium isolates. J Bacteriol (2005) 0.85
Molecular characterization of Ehrlichia interactions with tick cells and macrophages. Front Biosci (Landmark Ed) (2009) 0.85
Immunization with Ehrlichia P28 outer membrane proteins confers protection in a mouse model of ehrlichiosis. Clin Vaccine Immunol (2011) 0.84
Progress and obstacles in vaccine development for the ehrlichioses. Expert Rev Vaccines (2010) 0.84
Isolation and characterization of Ehrlichia chaffeensis RNA polymerase and its use in evaluating p28 outer membrane protein gene promoters. BMC Microbiol (2011) 0.79
Mini-review: Strategies for Variation and Evolution of Bacterial Antigens. Comput Struct Biotechnol J (2015) 0.79
Promoter analysis of macrophage- and tick cell-specific differentially expressed Ehrlichia chaffeensis p28-Omp genes. BMC Microbiol (2009) 0.79
Transcription of Ehrlichia chaffeensis genes is accomplished by RNA polymerase holoenzyme containing either sigma 32 or sigma 70. PLoS One (2013) 0.77
Isolation and characterization of an Ehrlichia sp. from a patient diagnosed with human ehrlichiosis. J Clin Microbiol (1991) 6.00
Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc Natl Acad Sci U S A (1996) 5.34
Energy metabolism of monocytic Ehrlichia. Proc Natl Acad Sci U S A (1989) 4.04
Immunodominant major outer membrane proteins of Ehrlichia chaffeensis are encoded by a polymorphic multigene family. Infect Immun (1998) 3.02
Sequential evaluation of dogs naturally infected with Ehrlichia canis, Ehrlichia chaffeensis, Ehrlichia equi, Ehrlichia ewingii, or Bartonella vinsonii. J Clin Microbiol (1998) 2.48
Ehrlichia canis-like agent isolated from a man in Venezuela: antigenic and genetic characterization. J Clin Microbiol (1996) 2.29
Isolation and characterization of Ehrlichia chaffeensis strains from patients with fatal ehrlichiosis. J Clin Microbiol (1997) 1.91
Persistent infection with Ehrlichia chaffeensis. Clin Infect Dis (1993) 1.85
Susceptibility of dogs to infection with Ehrlichia chaffeensis, causative agent of human ehrlichiosis. Am J Vet Res (1992) 1.81
Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J Infect Dis (1996) 1.79
Analysis of transcriptionally active gene clusters of major outer membrane protein multigene family in Ehrlichia canis and E. chaffeensis. Infect Immun (2001) 1.65
Characterization of the complete transcriptionally active ehrlichia chaffeensis 28 kDa outer membrane protein multigene family. Gene (2000) 1.61
Isolation and characterization of a new strain of Ehrlichia chaffeensis from a patient with nearly fatal monocytic ehrlichiosis. J Clin Microbiol (1995) 1.54
White-tailed deer as a potential reservoir of Ehrlichia spp. J Wildl Dis (1994) 1.53
The carrier status of sheep, cattle and African buffalo recovered from heartwater. Vet Parasitol (1989) 1.43
Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J Clin Microbiol (1998) 1.42
Genetic diversity of the 28-kilodalton outer membrane protein gene in human isolates of Ehrlichia chaffeensis. J Clin Microbiol (1999) 1.29
Primary isolation of Ehrlichia chaffeensis from patients with febrile illnesses: clinical and molecular characteristics. J Infect Dis (2000) 1.22
Genetic and antigenic diversity of Ehrlichia chaffeensis: comparative analysis of a novel human strain from Oklahoma and previously isolated strains. J Infect Dis (1997) 1.20
Variability in the 28-kDa surface antigen protein multigene locus of isolates of the emerging disease agent Ehrlichia chaffeensis suggests that it plays a role in immune evasion. Mol Cell Biol Res Commun (1999) 1.19
Ehrlichiosis--a cause of prolonged fever. Clin Infect Dis (1995) 1.17
Identification of Ehrlichia chaffeensis morulae in cerebrospinal fluid mononuclear cells. J Clin Microbiol (1992) 1.08
Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med (2011) 13.18
Person-to-person transmission of severe fever with thrombocytopenia syndrome virus. Vector Borne Zoonotic Dis (2011) 3.73
Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis--United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm Rep (2006) 3.32
Optimal germinal center responses require a multistage T cell:B cell adhesion process involving integrins, SLAM-associated protein, and CD84. Immunity (2010) 3.00
Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of São Paulo, Brazil, where Brazilian spotted fever is endemic. J Clin Microbiol (2004) 2.91
Follicular T-helper cell recruitment governed by bystander B cells and ICOS-driven motility. Nature (2013) 2.52
Complete genome sequence of Rickettsia typhi and comparison with sequences of other rickettsiae. J Bacteriol (2004) 2.44
Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med (2006) 2.30
Rickettsia sibirica infection in members of scientific expeditions to northern Asia. Lancet (2003) 2.20
SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat Rev Immunol (2009) 2.19
The Mg-chelatase H subunit of Arabidopsis antagonizes a group of WRKY transcription repressors to relieve ABA-responsive genes of inhibition. Plant Cell (2010) 2.13
Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients. J Infect Dis (2008) 1.97
Directed mutagenesis of the Rickettsia prowazekii pld gene encoding phospholipase D. Infect Immun (2009) 1.83
Rickettsia bellii and Rickettsia amblyommii in Amblyomma ticks from the State of Rondônia, Western Amazon, Brazil. J Med Entomol (2004) 1.77
Highways, byways and breadcrumbs: directing lymphocyte traffic in the lymph node. Trends Immunol (2007) 1.73
Unresolved problems related to scrub typhus: a seriously neglected life-threatening disease. Am J Trop Med Hyg (2013) 1.64
Pathogenesis of the viral hemorrhagic fevers. Annu Rev Pathol (2012) 1.63
Illuminating the landscape of in vivo immunity: insights from dynamic in situ imaging of secondary lymphoid tissues. Immunity (2004) 1.61
Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis (2013) 1.58
Detection of Rickettsia rickettsii in the tick Amblyomma cajennense in a new Brazilian spotted fever-endemic area in the state of Minas Gerais. Mem Inst Oswaldo Cruz (2006) 1.57
STAT5 protein negatively regulates T follicular helper (Tfh) cell generation and function. J Biol Chem (2012) 1.51
Clinical and epidemiological study on severe fever with thrombocytopenia syndrome in Yiyuan County, Shandong Province, China. Am J Trop Med Hyg (2013) 1.49
MicroRNAs of the miR-17∼92 family are critical regulators of T(FH) differentiation. Nat Immunol (2013) 1.48
Making friends in out-of-the-way places: how cells of the immune system get together and how they conduct their business as revealed by intravital imaging. Immunol Rev (2008) 1.47
The magnesium-chelatase H subunit binds abscisic acid and functions in abscisic acid signaling: new evidence in Arabidopsis. Plant Physiol (2009) 1.44
Characterization of the Bhanja serogroup viruses (Bunyaviridae): a novel species of the genus Phlebovirus and its relationship with other emerging tick-borne phleboviruses. J Virol (2013) 1.43
Arp2/3 complex-dependent actin networks constrain myosin II function in driving retrograde actin flow. J Cell Biol (2012) 1.42
Scrub typhus in previously unrecognized areas of endemicity in China. J Clin Microbiol (2010) 1.41
Cardiac arrest on induction of anesthesia due to triple vessel coronary artery disease despite a "Negative" angiogram. Anesthesiology (2002) 1.40
New manganese(II) azido coordination polymers with nicotinic/isonicotinic acids as coligands: synthesis, structure, and magnetic properties. Inorg Chem (2010) 1.39
First serologic evidence of human spotted fever group rickettsiosis in Korea. J Clin Microbiol (2004) 1.38
Emerging pathogens: challenges and successes of molecular diagnostics. J Mol Diagn (2008) 1.38
The developmental cycle of Ehrlichia chaffeensis in vertebrate cells. Cell Microbiol (2006) 1.35
An emerging hemorrhagic fever in China caused by a novel bunyavirus SFTSV. Sci China Life Sci (2013) 1.34
Histologic, serologic, and molecular analysis of persistent ehrlichiosis in a murine model. Am J Pathol (2004) 1.34
Fc-dependent polyclonal antibodies and antibodies to outer membrane proteins A and B, but not to lipopolysaccharide, protect SCID mice against fatal Rickettsia conorii infection. Infect Immun (2004) 1.33
Fatal human infection with Rickettsia rickettsii, Yucatán, Mexico. Emerg Infect Dis (2006) 1.33
An extended vision for dynamic high-resolution intravital immune imaging. Semin Immunol (2005) 1.32
An intradermal environment promotes a protective type-1 response against lethal systemic monocytotropic ehrlichial infection. Infect Immun (2006) 1.31
Expression of the Rickettsia prowazekii pld or tlyC gene in Salmonella enterica serovar Typhimurium mediates phagosomal escape. Infect Immun (2005) 1.30
Analysis of T helper cell responses during infection with Leishmania amazonensis. Am J Trop Med Hyg (2002) 1.28
Kinetics of antibody response to Ehrlichia canis immunoreactive proteins. Infect Immun (2003) 1.27
Detection of medically important Ehrlichia by quantitative multicolor TaqMan real-time polymerase chain reaction of the dsb gene. J Mol Diagn (2005) 1.26
Acute spotted fever rickettsiosis among febrile patients, Cameroon. Emerg Infect Dis (2004) 1.25
Pathogenesis of Lassa fever. Viruses (2012) 1.23
Detection of Rickettsia africae in patients and ticks along the coastal region of Cameroon. Am J Trop Med Hyg (2004) 1.21
Expression analysis of the T-cell-targeting chemokines CXCL9 and CXCL10 in mice and humans with endothelial infections caused by rickettsiae of the spotted fever group. Am J Pathol (2003) 1.21
Severe fever with thrombocytopenia syndrome, Shandong Province, China, 2011. Emerg Infect Dis (2014) 1.21
Prevalence of antibodies to spotted fever group rickettsiae in humans and domestic animals in a Brazilian spotted fever-endemic area in the state of São Paulo, Brazil: serologic evidence for infection by Rickettsia rickettsii and another spotted fever group Rickettsia. Am J Trop Med Hyg (2004) 1.19
Rickettsia felis in Ctenocephalides spp. fleas, Brazil. Emerg Infect Dis (2002) 1.19
Detection of Rickettsia felis in a New World flea species, Anomiopsyllus nudata (Siphonaptera: Ctenophthalmidae). J Med Entomol (2005) 1.18
Aponomma hydrosauri, the reptile-associated tick reservoir of Rickettsia honei on Flinders Island, Australia. Am J Trop Med Hyg (2003) 1.18
Molecular evidence for a spotted fever group Rickettsia species in the tick Amblyomma longirostre in Brazil. J Med Entomol (2004) 1.16
Mechanisms of immunity to Ehrlichia muris: a model of monocytotropic ehrlichiosis. Infect Immun (2004) 1.15
Isolation of circulating tumor cells in patients with hepatocellular carcinoma using a novel cell separation strategy. Clin Cancer Res (2011) 1.14
Identification and functional analysis of an immunoreactive DsbA-like thio-disulfide oxidoreductase of Ehrlichia spp. Infect Immun (2002) 1.14
Transcriptome analysis reveals the time of the fourth round of genome duplication in common carp (Cyprinus carpio). BMC Genomics (2012) 1.14
A mutation inactivating the methyltransferase gene in avirulent Madrid E strain of Rickettsia prowazekii reverted to wild type in the virulent revertant strain Evir. Vaccine (2005) 1.13
Experimental Ehrlichia chaffeensis infection in beagles. J Med Microbiol (2003) 1.12
Novel Immunoreactive glycoprotein orthologs of Ehrlichia spp. Ann N Y Acad Sci (2003) 1.12
Cooperation of three WRKY-domain transcription factors WRKY18, WRKY40, and WRKY60 in repressing two ABA-responsive genes ABI4 and ABI5 in Arabidopsis. J Exp Bot (2012) 1.11
The absence of Toll-like receptor 4 signaling in C3H/HeJ mice predisposes them to overwhelming rickettsial infection and decreased protective Th1 responses. Infect Immun (2008) 1.10
New insight into immunity and immunopathology of Rickettsial diseases. Clin Dev Immunol (2011) 1.10
Quantifying cellular interaction dynamics in 3D fluorescence microscopy data. Nat Protoc (2009) 1.09
Current status of immune mechanisms of killing of intracellular microorganisms. FEMS Microbiol Lett (2002) 1.09
Human ehrlichioses. Med Clin North Am (2002) 1.08
Effect of antibody on the rickettsia-host cell interaction. Infect Immun (2004) 1.08
Detection of a typhus group Rickettsia in Amblyomma ticks in the state of Nuevo Leon, Mexico. Ann N Y Acad Sci (2005) 1.08
Mechanisms of immunity against rickettsiae. New perspectives and opportunities offered by unusual intracellular parasites. Microbes Infect (2002) 1.08
Rickettsia hoogstraalii sp. nov., isolated from hard- and soft-bodied ticks. Int J Syst Evol Microbiol (2009) 1.08
Clinical features of hepatic angiomyolipoma. Hepatobiliary Pancreat Dis Int (2008) 1.07
Clinical manifestations, epidemiology, and laboratory diagnosis of human monocytotropic ehrlichiosis in a commercial laboratory setting. Clin Diagn Lab Immunol (2003) 1.07
Rickettsiosis of the genus Rickettsia in South America. Ann N Y Acad Sci (2003) 1.06
Human monocytotropic ehrlichiosis, Missouri. Emerg Infect Dis (2003) 1.05
The Arabidopsis Ca(2+) -dependent protein kinase CPK12 negatively regulates abscisic acid signaling in seed germination and post-germination growth. New Phytol (2011) 1.03
Cross-protection between distantly related spotted fever group rickettsiae. Vaccine (2003) 1.03
Evaluation of transovarial transmission and transmissibility of Ehrlichia chaffeensis (Rickettsiales: Anaplasmataceae) in Amblyomma americanum (Acari: Ixodidae). J Med Entomol (2003) 1.01
Rocky Mountain spotted fever--changing ecology and persisting virulence. N Engl J Med (2005) 1.01
Ehrlichia chaffeensis: a prevalent, life-threatening, emerging pathogen. Trans Am Clin Climatol Assoc (2004) 1.01
3D Mn(II) coordination polymer with alternating azide/azide/formate/formate bridged chains: synthesis, structure and magnetic properties. Dalton Trans (2009) 1.01
Lymphangitis in a Portuguese patient infected with Rickettsia sibirica. Emerg Infect Dis (2008) 1.00
Molecular and cellular pathobiology of Ehrlichia infection: targets for new therapeutics and immunomodulation strategies. Expert Rev Mol Med (2011) 1.00
Fatal spotted fever rickettsiosis, Minas Gerais, Brazil. Emerg Infect Dis (2003) 1.00
Constitutively active ezrin increases membrane tension, slows migration, and impedes endothelial transmigration of lymphocytes in vivo in mice. Blood (2011) 1.00
Transcription of the Rickettsia felis ompA gene in naturally infected fleas. Am J Trop Med Hyg (2005) 0.99
Differential interaction of dendritic cells with Rickettsia conorii: impact on host susceptibility to murine spotted fever rickettsiosis. Infect Immun (2007) 0.99
The endothelium as a target for infections. Annu Rev Pathol (2006) 0.98
Roles of the different components of magnesium chelatase in abscisic acid signal transduction. Plant Mol Biol (2012) 0.98
Does family history of cancer modify the effects of lifestyle risk factors on esophageal cancer? A population-based case-control study in China. Int J Cancer (2011) 0.97
Relative importance of T-cell subsets in monocytotropic ehrlichiosis: a novel effector mechanism involved in Ehrlichia-induced immunopathology in murine ehrlichiosis. Infect Immun (2007) 0.97
Ehrlichia species in Rhipicephalus sanguineus ticks in Cameroon. Vector Borne Zoonotic Dis (2007) 0.96